JP2022527630A5 - - Google Patents
Info
- Publication number
- JP2022527630A5 JP2022527630A5 JP2021560228A JP2021560228A JP2022527630A5 JP 2022527630 A5 JP2022527630 A5 JP 2022527630A5 JP 2021560228 A JP2021560228 A JP 2021560228A JP 2021560228 A JP2021560228 A JP 2021560228A JP 2022527630 A5 JP2022527630 A5 JP 2022527630A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- pharmaceutical composition
- composition according
- sucralose
- citric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962829784P | 2019-04-05 | 2019-04-05 | |
| US62/829,784 | 2019-04-05 | ||
| PCT/US2020/026696 WO2020206336A1 (en) | 2019-04-05 | 2020-04-03 | Pde9 inhibitors for treating sickle cell disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022527630A JP2022527630A (ja) | 2022-06-02 |
| JP2022527630A5 true JP2022527630A5 (https=) | 2023-04-10 |
Family
ID=72666968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021560228A Pending JP2022527630A (ja) | 2019-04-05 | 2020-04-03 | 鎌状赤血球症を治療するためのｐｄｅ９阻害剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220023302A1 (https=) |
| EP (1) | EP3946348A4 (https=) |
| JP (1) | JP2022527630A (https=) |
| CN (1) | CN114302724A (https=) |
| BR (1) | BR112021019876A2 (https=) |
| CA (1) | CA3136128A1 (https=) |
| IL (1) | IL286976A (https=) |
| WO (1) | WO2020206336A1 (https=) |
| ZA (1) | ZA202107544B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3865484T (pt) | 2015-07-07 | 2024-01-30 | H Lundbeck As | Inibidor da pde9 com esqueleto de imidazo pirazinona para tratamento de doenças periféricas |
| CA3100988A1 (en) | 2018-05-25 | 2019-11-28 | Imara Inc. | Monohydrate and crystalline forms of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7h-imidazo[1,5-a]pyrazin-8-one |
| CA3110680A1 (en) | 2018-08-31 | 2020-03-05 | Imara Inc. | Pde9 inhibitors for treating sickle cell disease |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009507032A (ja) * | 2005-09-02 | 2009-02-19 | アボット・ラボラトリーズ | 新規なイミダゾ系複素環 |
| JP4941977B2 (ja) * | 2007-04-11 | 2012-05-30 | 大蔵製薬株式会社 | ベンズイソキサゾール誘導体の経口ゼリー状医薬組成物 |
| BR112015007731B1 (pt) * | 2011-10-10 | 2022-05-31 | H. Lundbeck A/S | Composto, composição farmacêutica que o compreende e uso do mesmo |
| EP2868319A4 (en) * | 2012-06-29 | 2016-02-24 | Maruishi Pharma | ORAL PHARMACEUTICAL ARIPIPRAZONE PREPARATION |
| PT3865484T (pt) * | 2015-07-07 | 2024-01-30 | H Lundbeck As | Inibidor da pde9 com esqueleto de imidazo pirazinona para tratamento de doenças periféricas |
| US10045991B2 (en) * | 2016-04-04 | 2018-08-14 | Loxo Oncology, Inc. | Methods of treating pediatric cancers |
| MX2018016127A (es) * | 2016-07-06 | 2019-05-30 | Imara Inc | Inhibidores de pde9 para el tratamiento de enfermedades perifericas. |
| CN115746003B (zh) * | 2017-05-26 | 2024-08-09 | 卡都瑞恩医药公司 | 制备和使用pde9抑制剂的方法 |
| EP3965768A1 (en) * | 2019-05-07 | 2022-03-16 | Imara Inc. | Pde9 inhibitors for treating thalassemia |
-
2020
- 2020-04-03 EP EP20783704.8A patent/EP3946348A4/en not_active Withdrawn
- 2020-04-03 JP JP2021560228A patent/JP2022527630A/ja active Pending
- 2020-04-03 WO PCT/US2020/026696 patent/WO2020206336A1/en not_active Ceased
- 2020-04-03 CN CN202080041606.3A patent/CN114302724A/zh active Pending
- 2020-04-03 BR BR112021019876A patent/BR112021019876A2/pt not_active Application Discontinuation
- 2020-04-03 CA CA3136128A patent/CA3136128A1/en active Pending
-
2021
- 2021-10-04 IL IL286976A patent/IL286976A/en unknown
- 2021-10-04 US US17/493,677 patent/US20220023302A1/en not_active Abandoned
- 2021-10-07 ZA ZA2021/07544A patent/ZA202107544B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025142338A5 (https=) | ||
| CN101171005A (zh) | Pde4抑制剂罗氟司特与四氢生物蝶呤衍生物的组合 | |
| US8012503B2 (en) | Method of enhancing absorptions of transmucosal administration formulations | |
| ES2259098T3 (es) | Composiciones que comprenden ipatropio y xilometazolina para el tratamiento del resfriado comun. | |
| JP2022527630A5 (https=) | ||
| KR100841893B1 (ko) | 프레가발린 조성물 | |
| CA2782734C (en) | Nicotine containing formulation | |
| CN102470099A (zh) | 儿童用奥洛他定鼻腔喷雾方案 | |
| WO2016159897A1 (en) | Potassium citrate suspension | |
| JPH07505645A (ja) | 医薬組成物 | |
| ES2239802T3 (es) | Composiciones farmaceuticas. | |
| ES2791775A2 (es) | Formulaciones de epinefrina intranasal y metodos para el tratamiento de enfermedades | |
| JP5314014B2 (ja) | テルビブジンを含む医薬内用液 | |
| TWI327913B (en) | Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid | |
| CN105213402A (zh) | 一种畜禽复方恩诺沙星美洛昔康可溶性粉 | |
| PT1482938E (pt) | Composição farmacêutica de um inibidor da pde4 ou de um inibidor da pde3/4 e um antagonista dos receptores histamínicos | |
| JP2022536669A5 (https=) | ||
| WO2011093831A2 (en) | Effervescent formulations comprising cefprozil as active agent | |
| WO2018053423A1 (en) | Pharmaceutical composition of ibuprofen sodium for oral administration | |
| JP2003512421A5 (https=) | ||
| JPH11139970A (ja) | 経口液剤 | |
| ES2279707B1 (es) | Formulaciones orales que comprenden 3'-azidonucleosidos. | |
| JP2009507850A5 (https=) | ||
| CN121285367A (zh) | 包含布洛芬的药物组合物 | |
| JP2025506335A5 (https=) |